Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HeartBeam, Inc.BEAT · Entity 9039 | Chief Operating Officer | June 15, 2022 | June 17, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HeartBeam, Inc.
Report date June 15, 2022 · Filed June 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.30 · Expires 2032-06-15 | Direct | 38,000 |
Reported balance
After 2022-06-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-15 · Grant · Acquired 38,000 · Balance 38,000 F1: The options ("Options") have been issued from the 2022 Executive Incentive Plan, that was approved at the Annual Shareholder Meeting held on June 15, 2022. F2: The Option will vest and become exercisable with respect to 25% of the shares starting June 15, 2023 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date, such that 100% of the shares shall be fully vested and exercisable on June 15, 2027. All Options shall accelerate and vest in full upon the Company's termination of the Reporting Person's engagement with the Company following a change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: The options ("Options") have been issued from the 2022 Executive Incentive Plan, that was approved at the Annual Shareholder Meeting held on June 15, 2022.
F2: The Option will vest and become exercisable with respect to 25% of the shares starting June 15, 2023 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date, such that 100% of the shares shall be fully vested and exercisable on June 15, 2027. All Options shall accelerate and vest in full upon the Company's termination of the Reporting Person's engagement with the Company following a change in control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2022 Filed Jun 17, 2022 22:59 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantStock option (right to buy) · Derivative | 38,000 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0001779372-22-000021 · wf-form4_165550675086939.xml · derivative · entry 1 Baumel Alan · CIK 0001900685 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2032-06-15 F1 · shares: The options ("Options") have been issued from the 2022 Executive Incentive Plan, that was approved at the Annual Shareholder Meeting held on June 15, 2022. F2 · derivative.exercise_date: The Option will vest and become exercisable with respect to 25% of the shares starting June 15, 2023 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date, such that 100% of the shares shall be fully vested and exercisable on June 15, 2027. All Options shall accelerate and vest in full upon the Company's termination of the Reporting Person's engagement with the Company following a change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.